5.22 PREDICTORS OF GROWTH SUPPRESSION IN CHILDREN WITH ADHD TREATED WITH CENTRAL NERVOUS SYSTEM STIMULANTS

Author(s):  
James G. Waxmonsky ◽  
William E. Pelham ◽  
Raman Baweja ◽  
William E. Pelham
1961 ◽  
Vol 3 (3) ◽  
pp. 471-488 ◽  
Author(s):  
I. Setnikar ◽  
W. Murmann ◽  
M. J. Magistretti ◽  
P. Da Re ◽  
L. Verlicchi

1967 ◽  
Vol 10 (2) ◽  
pp. 214-222 ◽  
Author(s):  
Albert D. Cale ◽  
Herndon. Jenkins ◽  
Bernard V. Franko ◽  
John W. Ward ◽  
Carl D. Lunsford

PEDIATRICS ◽  
1973 ◽  
Vol 52 (5) ◽  
pp. 753-754
Author(s):  
Samuel Livingston ◽  
Wulfred Berman ◽  
Lydia L. Pauli

In the February 1973 issue of Pediatrics, the Committee on Drugs presented a concise review of the use of d-amphetamine (Dexedrine) and related central nervous system stimulants in children. They stated, "At present there are only two valid indications for the use of amphetamines in childhood: (1) the hyperkinetic syndrome, and (2) the rare condition of narcolepsy." It is unforunate that the Committee overlooked the use of amphetamines in epilepsy as another valid indication. The amphetamines play a very important role in the management of the epileptic patient, particularly in minimizing or alleviating anticonvulsant-induced drowsiness.


2021 ◽  
pp. 1-15
Author(s):  
Lori L. Scarpa ◽  
Dushyant Kshatriya ◽  
Nicholas T. Bello

2017 ◽  
Vol 20 (9) ◽  
pp. A898-A899
Author(s):  
M Ahmad ◽  
I Masood ◽  
D Umer ◽  
M Razzaq ◽  
U Baig ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document